Indian Pharmaceutical Supplier to Ukraine.
Ukrainian pharmaceutical demand is being served through three parallel channels right now: international donor procurement run by UN agencies and Crown Agents, the open ProZorro e-tender platform for state-side Ministry of Health buying, and direct private-hospital procurement in non-front-line oblasts. M Care has been an Indian source of supply on UN and Crown Agents-routed Ukraine programmes since the first donor-funded medicines pipeline opened. If you are an international procurement officer running a Ukraine programme, a ProZorro tender desk reading the Indian-supplier shortlist, or a hospital pharmacy buyer in Lviv, Kyiv or Odesa, this page is the operational version.
DLS Ukraine, ProZorro, UN procurement, in three layers.
The State Service of Ukraine on Medicines and Drugs Control (Derzhlikslyzhba, DLS) is the licensing gate for medicines in Ukraine. DLS accepts WHO-GMP as the manufacturing-site standard and CDSCO-issued Certificates of Pharmaceutical Product in WHO format. Marketing Authorisation runs in CTD format, valid for five years; Ukrainian-language labelling is required on the pack. DLS is gradually aligning with European Medicines Agency standards under Ukraine's EU candidate status, granted June 2022.
What makes Ukraine operationally different from other CIS or East European markets is the tri-channel demand structure. The first channel is ProZorro (prozorro.gov.ua), Ukraine's open e-procurement platform, where state-side Ministry of Health and hospital tenders are published transparently and any registered supplier can bid. The second channel is donor-funded procurement: UN agencies (UNICEF, UNDP, UNOPS), the WHO, Crown Agents and other international procurement agents source WHO-PQ or SRA-approved medicines directly for Ministry of Health-coordinated programmes, paid in USD via SWIFT to the supplier's specified bank. The third channel is direct private-hospital procurement in the non-front-line oblasts.
Sanctions context: Ukraine is not a sanctioned country. Ukraine is the protected party in the post-2022 sanctions architecture; Indian exporters face no compliance friction dealing with Ukraine. The risk profile is war-risk and logistics-risk, not sanctions-risk. SBI Ukraine and other Indian-bank correspondent relationships handle USD trade normally, and donor-funded payments via UN agencies or Crown Agents settle on standard SWIFT rails.
On the freight side, Boryspil (KBP) civilian air has been closed since February 2022. Air freight into Ukraine routes via Lviv (LWO) overland into Poland through Rzeszow (RZE) or Warsaw (WAW), trucked across the Polish-Ukrainian border at Korczowa or Krakovets. Sea freight via Odesa, Chornomorsk and Pivdennyi has run intermittently under grain-corridor and humanitarian arrangements. War-risk insurance premiums on shipments are elevated and we factor that into every quote.
Call & WhatsApp the Mumbai desk: +91 70156 05768 · info@mcareexports.com · Mon–Sat 09:30–18:30 IST
Six fronts in a tri-channel demand market.
UN and Crown Agents donor procurement
Indian-side supply into UN procurement (UNICEF, UNDP, UNOPS, WHO) and Crown Agents-routed Ukraine programmes. WHO-Prequalified product through documented Q-channels with Ukrainian-language pack inserts and full chain-of-custody documentation.
ProZorro tender response
Full-stack tender bids assembled in Mumbai for ProZorro state and hospital tenders: DLS-format dossier file, batch-specific stability data, pack-size variations, war-risk-aware freight-and-clearance schedule. Submissions in 5 to 8 working days from tender drop.
DLS registration support
End-to-end DLS Marketing Authorisation packs in CTD format, manufacturer site registration, per-product files in Ukrainian-language artwork. First-time generic registration runs 9 to 14 months from file submission to MA grant.
Lviv overland air routing
BOM to LWO via overland trucking from Polish airports (RZE Rzeszow or WAW Warsaw) since civilian Boryspil closure in February 2022. Cold-chain handled on validated Envirotainer and Pelican BioThermal lanes with continuous Sensitech logging through to receiving warehouse.
Hospital pharmacy supply (non-front-line)
Direct supply into hospital pharmacy procurement in Lviv, Kyiv, Odesa and other non-front-line oblasts. Cold-chain biologicals, oncology injectables, anti-infectives, where the donor-procurement channel does not cover the specific molecule profile.
Reconstruction medicines pipeline
Forward-positioned supply against the reconstruction phase: long-term contracts for chronic-disease medicines, oncology, NCD lines and the WHO-PQ-eligible essential medicines backbone. Mumbai-side stock holding against multi-year forecast where the agreement supports it.
How stock actually clears the Polish-Ukrainian border.
Boryspil International Airport (KBP) civilian air has been closed since February 2022 and remains so. The pharmaceutical air-freight pattern into Ukraine therefore routes via Polish airports and overland: Mumbai to Rzeszow (RZE) or Mumbai to Warsaw (WAW) on connecting services through Doha, Frankfurt or Istanbul, then trucked across the Polish-Ukrainian border at Korczowa-Krakovets or Hrebenne-Rava-Ruska, and onward to Lviv (LWO) or Kyiv. Air-plus-truck door-to-door typically runs 4 to 7 days for cold-chain consignments.
Sea freight via Odesa, Chornomorsk and Pivdennyi has run intermittently under grain-corridor and humanitarian arrangements since 2022, with the operational picture changing with each evolution of the conflict. We use sea routing only for ambient palletised supply where the shipment timing tolerance accepts variability, and only when the route is currently operational. Most pharmaceutical cargo flies via the Polish overland pattern.
War-risk insurance premiums on shipments into Ukraine are materially elevated and we factor them into every quote. Cold-chain operations on the BOM to LWO overland route use validated Envirotainer RKN e1 for 2 to 8 degree celsius bulk and Pelican BioThermal Credo Cube for smaller consignments, with continuous Sensitech temperature logging through the air leg, the Polish-side handling and the overland border crossing. Temperature-excursion incidents are rare but the logging chain is designed to flag any excursion at the moment it happens, not after it lands.
Commercial terms vary by channel. UN and Crown Agents donor procurement settles in USD via SWIFT on standard 30-day terms against documented delivery; this is the cleanest pharmaceutical-payment channel M Care runs. ProZorro state tenders settle on the contract-specified terms, typically 30 to 60 days post-delivery. Direct private-hospital supply to non-front-line oblasts settles by documentary LC at sight on first engagement, migrating to open account 30 days as the relationship establishes. UAH-denominated invoicing is rare; USD or EUR is standard.
Where Ukrainian demand is concentrated right now.
The Ukrainian pharmaceutical formulary in 2026 reflects a wartime and reconstruction-phase demand pattern. Donor-funded procurement (UN, Crown Agents, WHO, USAID) concentrates on the WHO Essential Medicines List backbone, the trauma-and-emergency medicines bench, oncology and supportive-care lines, anti-infectives (carbapenems, glycopeptides, antifungals) and cold-chain biologicals including insulin analogues. ProZorro state-tender demand overlaps with donor procurement and adds chronic-disease medicines for the non-front-line oblast hospital systems.
Our highest-volume Ukraine therapy areas are anti-infectives (carbapenems, glycopeptides, antifungals, broad-spectrum oral antibiotics) and oncology (paclitaxel, gemcitabine, oxaliplatin, biosimilars and supportive-care lines), with insulin analogues and the cold-chain biologic shelf as the fastest-growing slice. Anti-tuberculosis therapy runs through donor-funded procurement on WHO-PQ-eligible product. The cardiovascular and diabetes chronic-disease shelf is structurally important for the reconstruction-phase formulary.
Where Indian generic supply has stepped into actual demand gaps is on lines where European originators struggled with logistics or pulled back on Russia-Ukraine-area supply commitments. We are explicit on the categories where European-manufactured product remains the buyer's first choice, and we will not bid into a procurement where our manufacturing partner is not the right counterparty. On the categories where Indian WHO-GMP and WHO-PQ supply has been the real solution to a real shortage, the M Care manufacturing-partner network has run that supply through donor-procurement channels for multiple programme cycles.
An international procurement agent running a Ukraine donor programme came to us in 2024 needing supply on a third-line oncology agent where the previous supplier had failed two consecutive shipments. We identified a WHO-PQ-eligible SKU from one of our Hyderabad partners, prepared Q-channel documentation with Ukrainian-language pack inserts and shipped a validated trial consignment from Mumbai to Lviv via Warsaw inside seven working days. The procurement agent carried the molecule forward across the next four programme cycles and added two further oncology lines and an insulin analogue once the cold-chain audit cleared. War-risk insurance premiums factored in; landed cost held steady across the engagement.
Why M Care fits the donor-procurement and ProZorro brief.
Ukraine is one of the most demand-rich pharmaceutical markets on the planet right now, and one of the most operationally complex. The donor-procurement channel rewards WHO-Prequalified product, transparent supplier diligence, and on-schedule delivery against war-risk-aware freight planning. The ProZorro channel rewards DLS-fluent dossiers and Ukrainian-language artwork. The private-hospital channel rewards non-front-line geography awareness and cold-chain reliability. M Care has been on all three channels since the donor-funded medicines pipeline opened post-2022.
What we bring is the Mumbai HQ as the source of supply, manufacturing partners that hold WHO-Prequalification on selected oncology, anti-infective and cold-chain biologic SKUs, a documentation team that has assembled UN-procurement-format Q-channel files for multiple Ukraine programme cycles, and validated cold-chain operations on the BOM-to-LWO overland-via-Poland pattern. War-risk insurance on the freight side is factored into every quote, the Ukrainian-language artwork is prepared at source, and the Polish-side handling and border crossing are assigned to operations partners with three years of post-2022 track record on the lane. Where the question is which Indian counterparty actually delivers on Ukraine's tri-channel demand, the answer most often is M Care.
What Ukraine procurement officers ask us first.
Are your manufacturing partners DLS Ukraine-registered and WHO-Prequalified?
Yes, on the molecules we actively quote into Ukraine. DLS accepts WHO-GMP as the manufacturing standard and CDSCO-issued Certificates of Pharmaceutical Product. Where the molecule is WHO-PQ-eligible, our manufacturing partners hold concurrent Prequalification, which is what unlocks the UN and Crown Agents donor-procurement channel. We can provide WHO-PQ status, latest WHO-GMP inspection report, Site Master File extract and batch CoA ahead of any trial order.
Do you supply via UN agencies and Crown Agents donor procurement?
Yes. We have run Indian-side supply into UN procurement (UNICEF, UNDP, UNOPS, WHO) and Crown Agents-routed Ukraine programmes for multiple cycles since the donor-funded medicines pipeline opened post-2022. WHO-PQ-eligible product through documented Q-channels with Ukrainian-language pack inserts and full chain-of-custody documentation. USD-settled via SWIFT on the standard donor-procurement payment terms.
How do you respond to ProZorro tenders?
The Mumbai desk assembles full ProZorro submissions: DLS-format dossier file, batch-specific stability data, pack-size variations, war-risk-aware freight-and-clearance schedule and the procurement-template-specific commercial pack. Submissions turn around in 5 to 8 working days from tender drop. We will not bid on a line we cannot hold stock against given the war-risk freight realities.
What is the freight pattern given Boryspil's closure?
Civilian Boryspil air has been closed since February 2022. The default pharma-air pattern is BOM via Doha or Frankfurt to Rzeszow (RZE) or Warsaw (WAW) Poland, then trucked across the Polish-Ukrainian border at Korczowa-Krakovets or Hrebenne-Rava-Ruska, onward to Lviv (LWO) or Kyiv. Air-plus-truck door-to-door runs 4 to 7 days for cold-chain consignments. War-risk insurance premiums are factored into every quote.
Are there sanctions risks for an Indian exporter dealing with Ukraine?
No. Ukraine is the protected party in the post-2022 sanctions architecture, not a sanctioned country. Indian exporters face no compliance friction. SBI Ukraine and other Indian-bank correspondent relationships handle USD trade normally, and donor-procurement payments via UN agencies or Crown Agents settle on standard SWIFT rails. The risk profile is war-risk and logistics-risk, not sanctions-risk.
Can you supply hospital pharmacy in non-front-line oblasts directly?
Yes. Where the donor-procurement channel does not cover a specific molecule profile, we supply hospital pharmacy buyers in Lviv, Kyiv, Odesa and other non-front-line oblasts directly. Documentation adapts to the importer's DLS registration; cold-chain handled on the same validated overland-via-Poland pattern with Sensitech logging through to the receiving warehouse.
Is there a reconstruction-phase supply opportunity worth planning around?
Yes, and several donor-procurement agents have begun forward-positioning long-term medicine contracts against the reconstruction-phase need: chronic-disease medicines, oncology, NCD lines, the WHO-PQ-eligible essentials backbone. M Care holds Mumbai-side stock against multi-year forecast where the agreement supports it, and is ready to scale the manufacturing-partner allocation as the demand profile clarifies.
Why donor-procurement and ProZorro buyers choose M Care.
WHO-PQ on the donor channels
Manufacturing partners with concurrent WHO-Prequalification on selected oncology, anti-infective and cold-chain biologic SKUs. Q-channel documentation assembled at source for UN and Crown Agents programmes.
Polish overland pharma-air
BOM via Doha or Frankfurt to Rzeszow or Warsaw, trucked across Korczowa-Krakovets or Hrebenne-Rava-Ruska to Lviv or Kyiv. War-risk insurance and cold-chain Sensitech logging factored end-to-end.
Sanctions-clean, USD-settled
Ukraine is the protected party. SBI Ukraine and Indian-bank correspondent relationships handle USD trade normally; donor-funded procurement settles on standard SWIFT rails.
Top categories we ship to Ukraine
Oncology
Paclitaxel, gemcitabine, oxaliplatin, biosimilars and supportive-care lines for donor-procurement and hospital pharmacy.
Anti-infectives
Carbapenems, glycopeptides, antifungals, broad-spectrum oral antibiotics — war-supply backbone.
Diabetes & endocrine
Insulins (human and analogue biosimilars), oral antidiabetics for chronic-disease procurement.
Cardiovascular
Statins, ACE inhibitors, beta-blockers, DOACs and the heart-failure shelf.
Respiratory
Inhalers, nebuliser solutions, ICS-LABA combinations — 117+ SKUs.
CNS & neurology
Antiepileptics, antipsychotics, antidepressants and neuroprotective lines.
Routes that sit behind the Ukraine lane.
WHO-GMP compliance
Manufacturer registration and Site Master File support that DLS Ukraine and donor procurement agencies recognise.
CTD dossier preparation
DLS-ready CTD dossiers with Ukrainian-language artwork, Q-channel formats for UN and Crown Agents donor-procurement.
Cold-chain validated supply
Validated 2 to 8 degree celsius lanes from Mumbai via Polish airports overland to Lviv or Kyiv with continuous Sensitech logging.
Donor-procurement, ProZorro, or hospital direct.
Your enquiry goes directly to the account manager responsible for the Ukraine desk. WHO-PQ status flagged on receipt where the molecule qualifies; war-risk-aware freight quoted alongside.
Start a Ukraine enquiry → Back to all markets